US switches Sklice head-lice treatment to OTC

2 November 2020 - Deborah Wilkes


The US Food and Drug Administration (FDA) has switched Arbor Pharmaceuticals’ Sklice treatment for head lice from prescription-only to OTC status.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: